{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:13:32Z","timestamp":1791497612929,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s10753-023-01964-6","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T15:07:01Z","timestamp":1706108821000},"page":"1109-1126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Tetrandrine Alleviates Silica-induced Pulmonary Fibrosis Through PI3K\/AKT Pathway: Network Pharmacology Investigation and Experimental Validation"],"prefix":"10.1007","volume":"47","author":[{"given":"Ruimin","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjiang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"key":"1964_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/oemed-2019-106321","volume":"77","author":"P Shi","year":"2020","unstructured":"Shi, P., X. Xing, S. Xi, H. Jing, J. Yuan, Z. Fu, et al. 2020. Trends in global, regional and national incidence of pneumoconiosis caused by different aetiologies: an analysis from the Global Burden of Disease Study 2017. Occupational and Environmental Medicine 77: 407\u2013414.","journal-title":"Occupational and Environmental Medicine"},{"key":"1964_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12890-022-02040-9","volume":"22","author":"S Chen","year":"2022","unstructured":"Chen, S., M. Liu, and F. Xie. 2022. Global and national burden and trends of mortality and disability-adjusted life years for silicosis, from 1990 to 2019: results from the Global Burden of Disease study 2019. BMC Pulmonary Medicine 22: 240.","journal-title":"BMC Pulmonary Medicine"},{"issue":"8","key":"1964_CR3","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.3390\/ijms22084162","volume":"22","author":"J Adamcakova","year":"2021","unstructured":"Adamcakova, J., and D. Mokra. 2021. New insights into pathomechanisms and treatment possibilities for lung silicosis. International Journal of Molecular Sciences 22 (8): 4162.","journal-title":"International Journal of Molecular Sciences"},{"key":"1964_CR4","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(12)60235-9","volume":"379","author":"CC Leung","year":"2012","unstructured":"Leung, C.C., I.T. Yu, and W. Chen. 2012. Silicosis. The Lancet 379: 2008\u20132018.","journal-title":"The Lancet"},{"key":"1964_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.470","volume":"7","author":"K Levin","year":"2019","unstructured":"Levin, K., C. McLean, and R. Hoy. 2019. Artificial stone-associated silicosis: clinical-pathological-radiological correlates of disease. Respirology Case Reports 7: e470.","journal-title":"Respirology Case Reports"},{"key":"1964_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/oemed-2017-104428","volume":"75","author":"RF Hoy","year":"2018","unstructured":"Hoy, R.F., T. Baird, G. Hammerschlag, D. Hart, A.R. Johnson, P. King, et al. 2018. Artificial stone-associated silicosis: a rapidly emerging occupational lung disease. Occupational and Environmental Medicine 75: 3\u20135.","journal-title":"Occupational and Environmental Medicine"},{"key":"1964_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/resp.13744","volume":"25","author":"N Wu","year":"2020","unstructured":"Wu, N., C. Xue, S. Yu, and Q. Ye. 2020. Artificial stone-associated silicosis in China: a prospective comparison with natural stone-associated silicosis. Respirology 25: 518\u2013524.","journal-title":"Respirology"},{"key":"1964_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/toxsci\/kfac124","volume":"191","author":"R Ma","year":"2023","unstructured":"Ma, R., Y. Fan, X. Huang, J. Wang, S. Li, Y. Wang, et al. 2023. Lipid dysregulation associated with progression of silica-induced pulmonary fibrosis. Toxicological Sciences 191: 296\u2013307.","journal-title":"Toxicological Sciences"},{"key":"1964_CR9","first-page":"7433","volume":"15","author":"Z Chen","year":"2018","unstructured":"Chen, Z., L. Zhao, F. Zhao, G. Yang, and J.J. Wang. 2018. Tetrandrine suppresses lung cancer growth and induces apoptosis, potentially via the VEGF\/HIF-1alpha\/ICAM-1 signaling pathway. Oncology Letters 15: 7433\u20137437.","journal-title":"Oncology Letters"},{"key":"1964_CR10","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/cbdd.14202","volume":"101","author":"W Xue","year":"2023","unstructured":"Xue, W., R. Sun, Z. Hao, Z. Xing, H. Cheng, and L. Shao. 2023. Tetrandrine inhibits migration and invasion of BGC-823 and MKN-45 cells by regulating PI3K\/AKT\/mTOR signaling pathway. Chemical Biology & Drug Design 101: 927\u2013936.","journal-title":"Chemical Biology & Drug Design"},{"key":"1964_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1142\/S0192415X23500222","volume":"51","author":"T Liu","year":"2023","unstructured":"Liu, T., K. Li, Z. Zhang, J. Peng, J. Yang, B. Law, et al. 2023. Tetrandrine inhibits cancer stem cell characteristics and epithelial to mesenchymal transition in triple-negative breast cancer via SOD1\/ROS signaling pathway. American Journal of Chinese Medicine 51: 425\u2013444.","journal-title":"American Journal of Chinese Medicine"},{"key":"1964_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.phytochem.2016.02.005","volume":"125","author":"N Bhagya","year":"2016","unstructured":"Bhagya, N., and K.R. Chandrashekar. 2016. Tetrandrine\u2013a molecule of wide bioactivity. Phytochemistry 125: 5\u201313.","journal-title":"Phytochemistry"},{"key":"1964_CR13","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/s41401-021-00693-6","volume":"43","author":"MY Song","year":"2022","unstructured":"Song, M.Y., J.X. Wang, Y.L. Sun, Z.F. Han, Y.T. Zhou, Y. Liu, et al. 2022. Tetrandrine alleviates silicosis by inhibiting canonical and non-canonical NLRP3 inflammasome activation in lung macrophages. Acta Pharmacologica Sinica 43: 1274\u20131284.","journal-title":"Acta Pharmacologica Sinica"},{"key":"1964_CR14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11101-020-09673-w","volume":"19","author":"Y Jiang","year":"2020","unstructured":"Jiang, Y., M. Liu, H. Liu, and S. Liu. 2020. A critical review: traditional uses, phytochemistry, pharmacology and toxicology of Stephania tetrandra S. Moore (Fen Fang Ji). Phytochemistry Reviews 19: 449\u2013489.","journal-title":"Phytochemistry Reviews"},{"key":"1964_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.652901","volume":"12","author":"J Pang","year":"2021","unstructured":"Pang, J., Y. Luo, D. Wei, Z. Cao, X. Qi, M. Song, et al. 2021. Comparative transcriptome analyses reveal a transcriptional landscape of human silicosis lungs and provide potential strategies for silicosis treatment. Frontiers in Genetics 12: 652901.","journal-title":"Frontiers in Genetics"},{"key":"1964_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M., and S. Goto. 2000. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Research 28: 27\u201330.","journal-title":"Nucleic Acids Research"},{"key":"1964_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1749-8090-3-37","volume":"3","author":"S Karapolat","year":"2008","unstructured":"Karapolat, S., A. Sanli, A. Onen, U. Acikel, and O. Sivrikoz. 2008. Effects of retinoic acid on compensatory lung growth. Journal of Cardiothoracic Surgery 3: 37.","journal-title":"Journal of Cardiothoracic Surgery"},{"key":"1964_CR18","first-page":"893","volume":"120","author":"SV Szapiel","year":"1979","unstructured":"Szapiel, S.V., N.A. Elson, J.D. Fulmer, G.W. Hunninghake, and R.G. Crystal. 1979. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. The American Review of Respiratory Disease 120: 893\u2013899.","journal-title":"The American Review of Respiratory Disease"},{"key":"1964_CR19","first-page":"108","volume":"2","author":"EJ King","year":"1952","unstructured":"King, E.J. 1952. Silicosis. Lectures on the Scientific Basis of Medicine 2: 108\u2013138.","journal-title":"Lectures on the Scientific Basis of Medicine"},{"key":"1964_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/resp.14242","volume":"27","author":"RF Hoy","year":"2022","unstructured":"Hoy, R.F., M.F. Jeebhay, C. Cavalin, W. Chen, R.A. Cohen, E. Fireman, et al. 2022. Current global perspectives on silicosis-Convergence of old and newly emergent hazards. Respirology 27: 387\u2013398.","journal-title":"Respirology"},{"key":"1964_CR21","doi-asserted-by":"publisher","first-page":"210250","DOI":"10.1183\/16000617.0250-2021","volume":"31","author":"KS Vanka","year":"2022","unstructured":"Vanka, K.S., S. Shukla, H.M. Gomez, C. James, T. Palanisami, K. Williams, et al. 2022. Understanding the pathogenesis of occupational coal and silica dust-associated lung disease. European Respiratory Review 31: 210250.","journal-title":"European Respiratory Review"},{"key":"1964_CR22","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1111\/resp.13695","volume":"24","author":"H Barnes","year":"2019","unstructured":"Barnes, H., N. Goh, T.L. Leong, and R. Hoy. 2019. Silica-associated lung disease: An old-world exposure in modern industries. Respirology 24: 1165\u20131175.","journal-title":"Respirology"},{"key":"1964_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108232","volume":"240","author":"DN Weissman","year":"2022","unstructured":"Weissman, D.N. 2022. Progressive massive fibrosis: an overview of the recent literature. Pharmacology & Therapeutics 240: 108232.","journal-title":"Pharmacology & Therapeutics"},{"key":"1964_CR24","doi-asserted-by":"publisher","first-page":"1107967","DOI":"10.3389\/fmed.2023.1107967","volume":"10","author":"WH Wu","year":"2023","unstructured":"Wu, W.H., Y.H. Feng, C.Y. Min, S.W. Zhou, Z.D. Chen, L.M. Huang, et al. 2023. Clinical efficacy of tetrandrine in artificial stone-associated silicosis: a retrospective cohort study. Frontiers in Medicine 10: 1107967.","journal-title":"Frontiers in Medicine"},{"key":"1964_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e10201","volume":"8","author":"J Li","year":"2022","unstructured":"Li, J., Y. Wang, R. Wang, M.Y. Wu, J. Shan, Y.C. Zhang, et al. 2022. Study on the molecular mechanisms of tetrandrine against pulmonary fibrosis based on network pharmacology, molecular docking and experimental verification. Heliyon 8: e10201.","journal-title":"Heliyon"},{"key":"1964_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.739220","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu, Y., W. Zhong, J. Zhang, W. Chen, Y. Lu, Y. Qiao, et al. 2021. Tetrandrine modulates Rheb-mTOR signaling-mediated selective autophagy and protects pulmonary fibrosis. Frontiers in Pharmacology 12: 739220.","journal-title":"Frontiers in Pharmacology"},{"key":"1964_CR27","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1146\/annurev-immunol-032712-095946","volume":"31","author":"K Okkenhaug","year":"2013","unstructured":"Okkenhaug, K. 2013. Signaling by the phosphoinositide 3-kinase family in immune cells. Annual Review of Immunology 31: 675\u2013704.","journal-title":"Annual Review of Immunology"},{"key":"1964_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","volume":"18","author":"J Yang","year":"2019","unstructured":"Yang, J., J. Nie, X. Ma, Y. Wei, Y. Peng, and X. Wei. 2019. Targeting PI3K in cancer: mechanisms and advances in clinical trials. Molecular Cancer 18: 26.","journal-title":"Molecular Cancer"},{"key":"1964_CR29","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S1875-5364(15)30087-X","volume":"13","author":"Q Lv","year":"2015","unstructured":"Lv, Q., X.Y. Zhu, Y.F. Xia, Y. Dai, and Z.F. Wei. 2015. Tetrandrine inhibits migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes through down-regulating the expressions of Rac1, Cdc42, and RhoA GTPases and activation of the PI3K\/Akt and JNK signaling pathways. Chinese Journal of Natural Medicines 13: 831\u2013841.","journal-title":"Chinese Journal of Natural Medicines"},{"key":"1964_CR30","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/ijc.25817","volume":"129","author":"C Liu","year":"2011","unstructured":"Liu, C., K. Gong, X. Mao, and W. Li. 2011. Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. International Journal of Cancer 129: 1519\u20131531.","journal-title":"International Journal of Cancer"},{"key":"1964_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186615","volume":"12","author":"S Saito","year":"2017","unstructured":"Saito, S., Y. Zhuang, B. Shan, S. Danchuk, F. Luo, M. Korfei, et al. 2017. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFbeta-PI3K-Akt pathway. PLoS ONE 12: e186615.","journal-title":"PLoS ONE"},{"key":"1964_CR32","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","volume":"4","author":"AL Hopkins","year":"2008","unstructured":"Hopkins, A.L. 2008. Network pharmacology: the next paradigm in drug discovery. Nature Chemical Biology 4: 682\u2013690.","journal-title":"Nature Chemical Biology"},{"key":"1964_CR33","doi-asserted-by":"publisher","first-page":"6499","DOI":"10.1080\/21655979.2021.1973862","volume":"12","author":"J Yin","year":"2021","unstructured":"Yin, J., J. Lin, J. Yu, X. Wei, B. Zhu, and C. Zhu. 2021. Tetrandrine may treat membranous glomerulopathy via P13K\/Akt signaling pathway regulation: therapeutic mechanism validation using Heymann nephritis rat model. Bioengineered 12: 6499\u20136515.","journal-title":"Bioengineered"},{"key":"1964_CR34","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.2147\/DDDT.S307670","volume":"15","author":"W Shang","year":"2021","unstructured":"Shang, W., J. Zhang, H. Song, S. Zhu, A. Zhang, Y. Hua, et al. 2021. Mechanism of tetrandrine against endometrial cancer based on network pharmacology. Drug Design, Development and Therapy 15: 2907\u20132919.","journal-title":"Drug Design, Development and Therapy"},{"key":"1964_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/13880209.2021.2017468","volume":"60","author":"B Niu","year":"2022","unstructured":"Niu, B., S. Wei, J. Sun, H. Zhao, B. Wang, and G. Chen. 2022. Deciphering the molecular mechanism of tetrandrine in inhibiting hepatocellular carcinoma and increasing sorafenib sensitivity by combining network pharmacology and experimental evaluation. Pharmaceutical Biology 60: 75\u201386.","journal-title":"Pharmaceutical Biology"},{"key":"1964_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/10717544.2019.1573861","volume":"26","author":"X Que","year":"2019","unstructured":"Que, X., J. Su, P. Guo, Z. Kamal, E. Xu, S. Liu, et al. 2019. Study on preparation, characterization and multidrug resistance reversal of red blood cell membrane-camouflaged tetrandrine-loaded PLGA nanoparticles. Drug Delivery 26: 199\u2013207.","journal-title":"Drug Delivery"},{"key":"1964_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.978600","volume":"13","author":"L Mo","year":"2022","unstructured":"Mo, L., F. Zhang, F. Chen, L. Xia, Y. Huang, Y. Mo, et al. 2022. Progress on structural modification of Tetrandrine with wide range of pharmacological activities. Frontiers in Pharmacology 13: 978600.","journal-title":"Frontiers in Pharmacology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-023-01964-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-023-01964-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-023-01964-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T20:27:10Z","timestamp":1724444830000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-023-01964-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1964"],"URL":"https:\/\/doi.org\/10.1007\/s10753-023-01964-6","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,24]]},"assertion":[{"value":"16 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}